Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Jul;91(7):964-5.
doi: 10.1136/hrt.2004.049171.

Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment

V Tuseth, H J Jaatun, K Dickstein
Clinical Trial

Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment

V Tuseth et al. Heart. 2005 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier diagram showing the rate of conversion during the study period (n  =  100; p < 0.05).
See this image and copyright information in PMC

References

    1. Hou ZY, Chang MS, Chen CY, et al. Acute treatment of recent–onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomised digoxin controlled study. Eur Heart J 1995;16:521–8. - PubMed
    1. Clemo HF, Wood MA, Gilligan DM, et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 1998;11:594–8. - PubMed
    1. Cotter G, Blatt A, Kaluski E, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high dose amiodarone. Eur Heart J 1999;20:1833–42. - PubMed
    1. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852–923. - PubMed
    1. Ikeda N, Nademanee K, Kannan R, et al. Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J 1984;108:890–8. - PubMed